Patients with persistent atrial fibrillation taking oral verapamil exhibit a lower atrial frequency on the ECG

Annals of Noninvasive Electrocardiology

Volumn 7, Issue 2, 2002, Pages 92-97

  Bollmann, Andreas ^a   Sonne, Kai ^a   Esperer, Hans Dieter ^a   Toepffer, Ines ^a   Klein, Helmut U ^a  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

Atrial fibrillation; ECG; Electrical remodeling; Verapamil

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; VERAPAMIL;

ADULT; AGED; ARTICLE; ELECTROCARDIOGRAM; FEMALE; FOURIER TRANSFORMATION; HEART ATRIUM FIBRILLATION; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REFRACTORY PERIOD; SIGNAL PROCESSING;

EID: 0036083691     PISSN: 1082720X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2002.tb00148.x     Document Type: Article

References (20)

1. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans
2. Tachycardia-induced change of atrial refractory period in humans: Rate dependency and effects of antiarrhythmic drugs
3. Verapamil delays recovery from electrical remodeling after conversion of lone atrial fibrillation in humans
4. Postcardioversion atrial electrophysiologic changes induced by oral verapamil in patients with persistent atrial fibrillation
5. Increased dispersion and shortened refractoriness caused by verapamil in chronic atrial fibrillation
6. Attenuation of electrical remodeling in chronic atrial fibrillation following oral treatment with verapamil
7. Diagnosis of atrial fibrillation from surface electrocardiograms based on computer-detected atrial activity
8. Frequency analysis of human atrial fibrillation using the surface electrocardiogram and its response to ibutilide
9. Noninvasive assessment of the atrial cycle length during atrial fibrillation in man: Introducing, validating and illustrating a new ECG method
10. High-density mapping of electrically induced atrial fibrillation in humans
11. Circadian variations in atrial fibrillatory frequency in persistent human atrial fibrillation
12. On the multiple wavelet hypothesis of atrial fibrillation
13. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats
14. Effect of atrial fibrillation on atrial refractoriness in humans
15. Diurnal variations of the dominant cycle length of chronic atrial fibrillation
16. Verapamil prolongs atrial fibrillation by evoking an intense sympathetic neurohumoral effect
17. Autonomic modulation of the atrial cycle length by the head up tilt test: Noninvasive evaluation in patients with chronic atrial fibrillation
18. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: Effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol
19. Update on atrial remodeling owing to rate. Does atrial fibrillation always 'beget' atrial fibrillation?
20. Noninvasive assessment of fibrillatory activity in patients with paroxysmal and persistent atrial fibrillation using the Holter ECG